Role of T lymphocytes in the pathogenesis of Chlamydia disease.

Vaccines are needed to prevent the oculogenital diseases of Chlamydia trachomatis. Infected hosts develop immunity, although temporary, and experimental vaccines have yielded significant protective immunity in animal models, fueling the impetus for a vaccine. Because infections cause sequelae, the functional relationship between infection- and vaccine-induced immunity is unclear. We hypothesized that infection- and vaccine-induced immunity are functionally distinct, particularly in the ability to prevent sequelae. Chlamydia-immune mice, with immunity generated by either a previous infection or vaccination, exhibited a significant degree of protective immunity, marked by a lower-intensity, abbreviated course of infection. However, vaccinated mice were protected from infertility, whereas preinfected mice were not. Thus, infection-induced immunity does not prevent the pathologic process leading to infertility. Furthermore, T cell subsets, especially CD8 T cells, play a major role in Chlamydia-induced infertility. The results have important implications for the immunopathogenesis of chlamydial disease and new vaccine strategies.

[1]  Ding Chen,et al.  The Chlamydial Plasmid-Encoded Protein pgp3 Is Secreted into the Cytosol of Chlamydia-Infected Cells , 2008, Infection and Immunity.

[2]  B. Arulanandam,et al.  Antigen-Specific CD4+ T Cells Produce Sufficient IFN-γ to Mediate Robust Protective Immunity against Genital Chlamydia muridarum Infection1 , 2008, The Journal of Immunology.

[3]  R. Brunham,et al.  The arrested immunity hypothesis and the epidemiology of chlamydia control. , 2008, Sexually transmitted diseases.

[4]  M. Umemura,et al.  Interleukin‐17 as an Effector Molecule of Innate and Acquired Immunity against Infections , 2007, Microbiology and immunology.

[5]  C. Andrews,et al.  Plasmid-Deficient Chlamydia muridarum Fail to Induce Immune Pathology and Protect against Oviduct Disease1 , 2007, The Journal of Immunology.

[6]  A. García-Sastre,et al.  Live‐attenuated influenza viruses as delivery vectors for Chlamydia vaccines , 2007, Immunology.

[7]  J. Lillard,et al.  Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[8]  R. Brunham,et al.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.

[9]  H. Thio,et al.  Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  S. Fukuyama,et al.  NALT- versus PEYER'S-patch-mediated mucosal immunity , 2004, Nature Reviews Immunology.

[11]  Qing He,et al.  Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens , 2004, Expert review of vaccines.

[12]  Peri Nagappan,et al.  Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. , 2003, The Journal of infectious diseases.

[13]  R. Brunham,et al.  Immunogenetic Correlates for Chlamydia trachomatis–Associated Tubal Infertility , 2003, Obstetrics and gynecology.

[14]  F. Eko,et al.  Contemporary approaches to designing and evaluating vaccines against Chlamydia , 2003, Expert review of vaccines.

[15]  Robert E. Johnson,et al.  Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections -- 2002 , 2002 .

[16]  H. Caldwell,et al.  Immunity to Murine Chlamydial Genital Infection , 2002, Infection and Immunity.

[17]  M. Starnbach,et al.  T cell responses to Chlamydia trachomatis. , 2002, Current opinion in microbiology.

[18]  G. Byrne,et al.  Emerging strategies in the diagnosis, prevention and treatment of chlamydial infections , 2001 .

[19]  W. Levine,et al.  Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretions. , 2001, Sexually transmitted diseases.

[20]  R. Stephens,et al.  Chlamydia outer membrane protein discovery using genomics. , 2001, Current opinion in microbiology.

[21]  R. Stephens Chlamydial genomics and vaccine antigen discovery. , 2000, The Journal of infectious diseases.

[22]  F. Eko,et al.  Suppression of Endogenous IL-10 Gene Expression in Dendritic Cells Enhances Antigen Presentation for Specific Th1 Induction: Potential for Cellular Vaccine Development1 , 2000, The Journal of Immunology.

[23]  W. Levine,et al.  Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. , 1999, Sexually transmitted diseases.

[24]  J. Penninger,et al.  Chlamydia infections and heart disease linked through antigenic mimicry. , 1999, Science.

[25]  R. Brunham,et al.  Pathogenesis of Chlamydia induced pelvic inflammatory disease. , 1999, Sexually transmitted infections.

[26]  R. Rank Models of Immunity , 1999 .

[27]  R. Stephens Chlamydia: Intracellular Biology, Pathogenesis, And Immunity , 1999 .

[28]  H. Caldwell,et al.  Vaccination against Chlamydial Genital Tract Infection after Immunization with Dendritic Cells Pulsed Ex Vivo with Nonviable Chlamydiae , 1998, The Journal of experimental medicine.

[29]  C. Black,et al.  Route of Infection That Induces a High Intensity of Gamma Interferon-Secreting T Cells in the Genital Tract Produces Optimal Protection against Chlamydia trachomatis Infection in Mice , 1998, Infection and Immunity.

[30]  A. Stagg,et al.  Protection against Ascending Infection of the Genital Tract by Chlamydia trachomatis Is Associated with Recruitment of Major Histocompatibility Complex Class II Antigen-Presenting Cells into Uterine Tissue , 1998, Infection and Immunity.

[31]  E. Peterson,et al.  Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection. , 1998, Journal of medical microbiology.

[32]  H. Caldwell,et al.  Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice. , 1998, Journal of immunology.

[33]  E. Peterson,et al.  Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge , 1997, Infection and immunity.

[34]  W. M. Mac Kenzie,et al.  Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. , 1997, American journal of obstetrics and gynecology.

[35]  M. Russell,et al.  Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system , 1997, Immunologic research.

[36]  Michael de la Maza,et al.  A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. , 1995 .

[37]  L. M. de la Maza,et al.  A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. , 1995, Vaccine.

[38]  J. Paavonen Chlamydia trachomatis--a major threat to reproduction. , 1993, European journal of obstetrics, gynecology, and reproductive biology.

[39]  M. Jenkins,et al.  Costimulating factors and signals relevant for antigen presenting cell function. , 1993, Advances in experimental medicine and biology.

[40]  S. Thompson,et al.  Pelvic Inflammatory Disease and Fertility: A Cohort Study of 1,844 Women with Laparoscopically Verified Disease and 657 Control Women with Normal Laparoscopic Results , 1992, Sexually transmitted diseases.

[41]  D. Taylor-Robinson,et al.  Genetic susceptibility to chlamydial salpingitis and subsequent infertility in mice. , 1992, Journal of reproduction and fertility.

[42]  R. Rank,et al.  Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis , 1989, Infection and immunity.

[43]  B. Katz,et al.  Effect of Prior Sexually Transmitted Disease on the Isolation of Chlamydia trachomatis , 1987, Sexually transmitted diseases.

[44]  U. Kees,et al.  A method for testing the specificity of influenza A virus-reactive memory cytotoxic T lymphocyte (CTL) clones in limiting dilution cultures. , 1984, Journal of immunological methods.

[45]  E. Puré,et al.  21 – Production of Lymphokines by Murine T Cells Grown in Limiting Dilution and Long-Term Cultures , 1982 .

[46]  C. Fathman,et al.  Isolation, characterization and utilization of T-lymphocyte clones edited by C. Garrison Fathman and Frank W. Fitch, Academic Press, 1982. £39.40/ $59.50 (xxviii + 549 pages) ISBN 0 122 49920 4. , 1983, Immunology today.